Journal article
Revisiting Race and the Benefit of RAS Blockade in Heart Failure
Abstract
Importance: Concerns have arisen that renin-angiotensin system (RAS) blockers are less effective in Black patients than non-Black patients with heart failure and reduced ejection fraction (HFrEF).
Objective: To determine whether the effects of RAS blockers on cardiovascular outcomes differ between Black patients and non-Black patients with HFrEF.
Authors
Shen L; Lee MMY; Jhund PS; Granger CB; Anand IS; Maggioni AP; Pfeffer MA; Solomon SD; Swedberg K; Yusuf S
Journal
JAMA, Vol. 331, No. 24, pp. 2094–2104
Publisher
American Medical Association (AMA)
Publication Date
June 25, 2024
DOI
10.1001/jama.2024.6774
ISSN
0098-7484